Recent statements issued by the New England Journal of Medicine and the Lancet share significant concern related to the credibility of two major studies evaluating the safety and efficacy of hydroxychloroquine to prevent and treat COVID-19.
To support policyholders as they resume operations, MLMIC has recorded a podcast with recommendations and key considerations for safely and effectively reopening.
The Scope: Medical Edition, MLMIC’s new risk management publication, includes a case study on the disastrous effects of “anchoring,” guidance on transitioning medical practices back to post COVID-19 operations and more.
A news report issued by the University of Minnesota’s Center for Infectious Disease Research and Policy shares concern related to extensive use of antibiotics to treat COVID-19, a practice that may be accelerating antibiotic resistance.
You have been subscribed.
There was a problem submitting the form, please reload the page and try again.
